NASDAQ:TRDA

Entrada Therapeutics Stock Signals

etoro logo Buy TRDA
*Your capital is at risk
$8.47
-0.280 (-3.20%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.138 21 days ( -35.52 % )
Last Price $8.47 -3.20 %
High/ Low $8.17 - $9.04 25.52%
Chg 7 Days 16.67 % $7.26 $8.47
Chg 30 Days 44.29 % $5.87 $8.47
Chg 12 mos -52.55 % $17.85 $8.47
Trend - 3 mos 39.99 % Width: 33.58 %
Trend - 12 mos -60.04 % Width: 516.14 %
Pred. range - 3 mos $9.28 - $12.40 9.61 % - 46.42 %
Pred. range - 12 mos $0.563 - $3.47 -93.36 % - -59.07 %
Short MA avg 3 mos Buy Nov 04, 2025 - 10 days
Long MA avg 3 mos Buy Sep 24, 2025 - 39 days
Short/Long MA avg 3 mos Buy Sep 25, 2025 - 38 days
Short MA avg 12 mos Buy Sep 24, 2025 - 39 days
Long MA avg 12 mos Buy Oct 20, 2025 - 21 days
Short/Long MA avg 12 mos Buy Oct 27, 2025 - 16 days
Pivot Short Sell Nov 13, 2025 - 3 days
Bollinger Buy Oct 27, 2025 - 16 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT ENTRADA THERAPEUTICS, INC.
Entrada Therapeutics
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE